Demant A/S (OTCMKTS:WILYY) Rating Increased to Overweight at Morgan Stanley

Demant A/S (OTCMKTS:WILYY) was upgraded by analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating in a report issued on Tuesday.

Separately, Jefferies Financial Group upgraded Demant A/S from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, March 18th. One investment analyst has rated the stock with a Strong Buy rating and one has issued a Buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Strong Buy”.

Demant A/S Stock Performance

Shares of OTCMKTS:WILYY opened at $19.25 on Tuesday. The company has a current ratio of 1.36, a quick ratio of 1.00 and a debt-to-equity ratio of 1.65. The stock has a fifty day moving average of $18.08 and a 200-day moving average of $16.35. Demant A/S has a one year low of $13.45 and a one year high of $21.30.

Demant A/S Company Profile

Demant A/S is a Denmark-based global hearing health care company specializing in the development, manufacture and distribution of hearing solutions and audiological diagnostic instruments. The company’s flagship brands include Oticon, Bernafon and Sonic, which offer a range of hearing aids designed to address various levels of hearing loss. In addition to personal hearing devices, Demant provides diagnostic equipment such as audiometers and tympanometers, supporting hearing care professionals in accurate assessment and fitting of hearing solutions.

Beyond hearing aids and diagnostics, Demant’s product portfolio extends to hearing implants—cochlear and bone-anchored systems—through its Oticon Medical division.